References

Berry, S.J., D.S. Coffey, P.C. Walsh and L.L. Ewing, 1984. The development of human benign prostatic hyperplasia with age. J. Urol., 132: 474-479.
PubMed  |  Direct Link  |  

Bolton, S. and C. Bon, 2004. Pharmaceutical Statistics. Practical and Clinical Applications, Revised and Expanded. 5th Edn., Marcell Dekker Inc., New York, USA., ISBN: 0-8247-4695-3, pp: 83-88.

Chon, J.K., A. Borkowski, A. Partin, J.T. Isaacs, S.C. Jacobs and N. Kyprianou, 1999. (1)-Adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J. Urol., 161: 2002-2008.
PubMed  |  Google  |  

Colombel, M., F. Vacherot, S.G. Diez, E. Fontaine, R. Buttyan and D. Chopin, 1998. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia. Br. J. Urol., 82: 380-385.
CrossRef  |  PubMed  |  Direct Link  |  

Cotran, R.S., V. Kumar and T. Collins, 2004. Robbins Pathologic Basis of Disease. 7th Edn., Saunders Co., Philadelphia, ISBN: 81-8147-528-3, pp: 1048-1049.

Jacobson, M.D., M. Weil and M.C. Raff, 1997. Programmed cell death in animal development. Cell, 88: 347-354.
CrossRef  |  PubMed  |  Direct Link  |  

Janku, F., J. Novotny, I. Julis, I. Julisova, L. Pecen and G. Kocmanova et al., 2005. KIT receptor is expressed in >50% of early-stage malignant melanoma: A retrospective study of 261 patients. Melanoma Res., 15: 251-256.
CrossRef  |  PubMed  |  Direct Link  |  

Jefferson, K.P., R.A. Persad and J.M.P. Holly, 2000. Apoptosis and its relevant to urologist. BJU Int., 86: 598-606.
CrossRef  |  PubMed  |  Direct Link  |  

Kyprianou, N., H.C. Tu and C. Stephen, 1996. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum. Pathol., 27: 668-675.
CrossRef  |  PubMed  |  Direct Link  |  

Royuela, M., M.P. de Miguel, F.R. Bethencourt, B. Fraile, M.I. Arenas and R. Paniagua, 2000. IL-2, its receptors and BCL-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: Immunohistochemical comparative analysis. Growth Factors, 18: 135-136.
CrossRef  |  PubMed  |  Direct Link  |  

Thomas, L., A. Wright, C. Lazier, P. Cohen and R. Rittmaster, 2000. Prostatic involution in men taking finasteride is associated with elevated levels of Insulin-like Growth Factor Binding Proteins (IGFBPs)-2, 4 and 5. Prostate, 42: 203-210.
CrossRef  |  PubMed  |  

Trachtenberg, J., L.L. Hicks and P.C. Walsh, 1980. Androgen and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia. J. Clin. Invest., 65: 105l-1059.
CrossRef  |  PubMed  |  Direct Link  |  

Wright, A.S., L.N. Thomas, R.C. Douglas, C.B. Lazier and R.S. Rittmaster, 1996. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat. J. Clin. Invest., 98: 2558-2563.
CrossRef  |  PubMed  |  Direct Link  |